PHARMA LEYENS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMA LEYENS
Largest movements
- Receivables within one year -€79,497
down €79,497 (-46.2%), from €172,060 to €92,563
of which Trade receivables: -€73,030
- Intangible fixed assets -€31,250
down €31,250 (-75.0%), from €41,667 to €10,417
- Tangible fixed assets -€13,444
down €13,444 (-19.7%), from €68,074 to €54,630
of which Furniture and vehicles: -€11,934
- Stocks and contracts -€12,379
down €12,379 (-10.7%), from €115,436 to €103,057
- Cash +€5,646
up €5,646 (+13.9%), from €40,558 to €46,204
mainly Receivables within one year (+€79,497) and Depreciation (+€48,736)
- Debts after one year -€64,300
down €64,300 (-41.8%), from €153,660 to €89,361
- Profit (loss) carried forward -€64,190
down €64,190 (-73.2%), from €87,727 to €23,537
- Trade debts -€18,120
down €18,120 (-15.3%), from €118,094 to €99,974
- Other debts +€15,549
up €15,549 (+571%), from €2,725 to €18,273
- Gross operating margin -€44,685
down €44,685 (-28.2%), from €158,260 to €113,575
- Staff costs -€3,406
down €3,406 (-3.5%), from €97,868 to €94,461
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €442,706 | €311,356 | -€131,350 | -29.7% |
| Fixed assets | 21/28 | €111,365 | €66,671 | -€44,694 | -40.1% |
| Intangible fixed assets | 21 | €41,667 | €10,417 | -€31,250 | -75.0% |
| Tangible fixed assets | 22/27 | €68,074 | €54,630 | -€13,444 | -19.7% |
| Plant, machinery and equipment | 23 | €2,948 | €3,181 | +€233 | +7.9% |
| Furniture and vehicles | 24 | €29,288 | €17,354 | -€11,934 | -40.7% |
| Other tangible fixed assets | 26 | €35,838 | €34,095 | -€1,743 | -4.9% |
| Financial fixed assets | 28 | €1,624 | €1,624 | = | 0.0% |
| Current assets | 29/58 | €331,341 | €244,685 | -€86,656 | -26.2% |
| Stocks and contracts in progress | 3 | €115,436 | €103,057 | -€12,379 | -10.7% |
| Stocks | 30/36 | €115,436 | €103,057 | -€12,379 | -10.7% |
| Amounts receivable within one year | 40/41 | €172,060 | €92,563 | -€79,497 | -46.2% |
| Trade receivables | 40 | €146,386 | €73,357 | -€73,030 | -49.9% |
| Other amounts receivable | 41 | €25,674 | €19,206 | -€6,467 | -25.2% |
| Cash at bank and in hand | 54/58 | €40,558 | €46,204 | +€5,646 | +13.9% |
| Deferred charges and accrued income | 490/1 | €3,287 | €2,861 | -€426 | -13.0% |
| Total equity and liabilities | 10/49 | €442,706 | €311,356 | -€131,350 | -29.7% |
| Equity | 10/15 | €107,727 | €43,537 | -€64,190 | -59.6% |
| Contributions | 10/11 | €20,000 | €20,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €87,727 | €23,537 | -€64,190 | -73.2% |
| Amounts payable | 17/49 | €334,979 | €267,819 | -€67,160 | -20.0% |
| Amounts payable after more than one year | 17 | €153,660 | €89,361 | -€64,300 | -41.8% |
| Financial debts | 170/4 | €153,660 | €89,361 | -€64,300 | -41.8% |
| Amounts payable within one year | 42/48 | €181,319 | €178,459 | -€2,860 | -1.6% |
| Current portion of amounts payable after more than one year | 42 | €40,885 | €41,800 | +€914 | +2.2% |
| Financial debts | 43 | €1,022 | - | -€1,022 | |
| Credit institutions | 430/8 | €1,022 | - | -€1,022 | |
| Trade debts | 44 | €118,094 | €99,974 | -€18,120 | -15.3% |
| Suppliers | 440/4 | €118,094 | €99,974 | -€18,120 | -15.3% |
| Taxes, remuneration and social security | 45 | €18,593 | €18,411 | -€181 | -1.0% |
| Taxes | 450/3 | €4,581 | €1,462 | -€3,118 | -68.1% |
| Remuneration and social security | 454/9 | €14,012 | €16,949 | +€2,937 | +21.0% |
| Other amounts payable | 47/48 | €2,725 | €18,273 | +€15,549 | +571% |
| Remuneration, social security and pensions | 62 | €97,868 | €94,461 | -€3,406 | -3.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €49,799 | €48,736 | -€1,064 | -2.1% |
| Other operating charges | 640/8 | €1,071 | €1,035 | -€36 | -3.4% |
| Gross operating margin | 9900 | €158,260 | €113,575 | -€44,685 | -28.2% |
| Operating profit (loss) | 9901 | €9,522 | -€30,657 | -€40,178 | |
| Financial income | 75/76B | €1,640 | €994 | -€645 | -39.3% |
| Recurring financial income | 75 | €1,640 | €994 | -€645 | -39.3% |
| Financial charges | 65/66B | €3,744 | €4,226 | +€482 | +12.9% |
| Recurring financial charges | 65 | €3,744 | €4,226 | +€482 | +12.9% |
| Profit (loss) for the period before taxes | 9903 | €7,417 | -€33,889 | -€41,306 | |
| Income taxes | 67/77 | €1,698 | €302 | -€1,397 | -82.2% |
| Profit (loss) for the period | 9904 | €5,719 | -€34,190 | -€39,909 | |
| Profit (loss) for the period to be appropriated | 9905 | €5,719 | -€34,190 | -€39,909 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 18 October 2026 via checked.be.